Package Inspection Featured Articles
-
Why A Dynamic, Digital Defect Library Is Now A Regulatory Expectation
9/17/2025
Maintaining a dynamic, digital defect library is essential for modern sterile manufacturing. Learn how this approach helps ensure consistency in batch disposition and supports regulatory compliance.
-
Test Kit Management: The Hidden Weak Point In Your Visual Inspection Program
9/17/2025
A proper test kit management program is no longer a “nice-to-have”—it’s a compliance necessity. Without a structured system, you risk inspector drift, failed audits, and errors in batch release.
-
Advancing Drug Product Quality Through AVI And Future-Ready Infrastructure
9/5/2025
Automated visual inspection (AVI) combines robotics, precision imaging, and sophisticated defect-recognition software to provide a scalable solution for expanding pipelines and rises in production volumes.
-
Why Is It Important To Have Properly Trained Visual Inspectors?
8/4/2025
Properly trained visual inspectors are crucial for identifying defects in parenteral drugs, safeguarding patient safety and product quality.
-
Building A High-Fidelity Manual Baseline For Tomorrow's Automated Inspection
7/14/2025
Future-proof your pharma manufacturing. Discover why manual visual inspection remains foundational and how advanced software can build a high-fidelity baseline for automation success.
-
6 Things To Consider During Visual Inspection Operations
7/14/2025
Even with automation, manual visual inspection remains vital in sterile drug manufacturing. Discover six advanced considerations for refining your operations, ensuring compliance, and minimizing costs.
-
How Software-Enabled Manual Visual Inspection Can Boost Your ROI
7/14/2025
Unlock hidden cost savings in pharma manufacturing. Learn how software-enabled manual visual inspection enhances efficiency, data integrity, and regulatory readiness without full automation's capital expense.
-
What Is The Position Of Regulatory Authorities On PUPSIT?
5/2/2025
PUPSIT and other integrity testing methods are crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines.
-
ICH Revises Q1 Guideline, Advancing Stability Testing Standards
4/24/2025
In April 2025, the International Council for Harmonisation (ICH) released draft ICH Q1: Stability Testing of Drug Substances and Drug Products for public consultation. This new draft guideline represents the first major overhaul of global stability testing standards in over two decades.
-
Amgen's Deep Learning Approach To Vial Inspection
3/31/2025
The company is testing how artificial intelligence can help bring down the number of false rejections caused by factors like glare on the glass or bubbles in the vial.